HN2006014095A - Forma cristalina ortorrombica del maleato de asenapina - Google Patents

Forma cristalina ortorrombica del maleato de asenapina

Info

Publication number
HN2006014095A
HN2006014095A HN2006014095A HN2006014095A HN2006014095A HN 2006014095 A HN2006014095 A HN 2006014095A HN 2006014095 A HN2006014095 A HN 2006014095A HN 2006014095 A HN2006014095 A HN 2006014095A HN 2006014095 A HN2006014095 A HN 2006014095A
Authority
HN
Honduras
Prior art keywords
orthromby
crystal form
asenapine maleate
asenapine
maleate
Prior art date
Application number
HN2006014095A
Other languages
English (en)
Inventor
Johannes Heeres Gerardus
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36617328&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN2006014095(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of HN2006014095A publication Critical patent/HN2006014095A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Abstract

La invencion se refiere a una nueva forma cristalina de asenapina, a metodos para su preparacion y a composiciones farmaceuticas que comprenden dicha forma cristalina.
HN2006014095A 2005-04-07 2006-04-06 Forma cristalina ortorrombica del maleato de asenapina HN2006014095A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05102742 2005-04-07
EP05102969 2005-04-14

Publications (1)

Publication Number Publication Date
HN2006014095A true HN2006014095A (es) 2010-08-19

Family

ID=36617328

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2006014095A HN2006014095A (es) 2005-04-07 2006-04-06 Forma cristalina ortorrombica del maleato de asenapina

Country Status (31)

Country Link
EP (2) EP1917267B1 (es)
JP (1) JP5058151B2 (es)
KR (1) KR101422843B1 (es)
AR (1) AR056306A1 (es)
AT (2) ATE418556T1 (es)
AU (1) AU2006231617B2 (es)
BR (1) BRPI0609741A8 (es)
CA (1) CA2603509C (es)
CY (2) CY1106902T1 (es)
DE (2) DE602006004463D1 (es)
DK (2) DK1710245T3 (es)
DO (1) DOP2006000082A (es)
ES (2) ES2293626T3 (es)
GT (1) GT200600135A (es)
HN (1) HN2006014095A (es)
HR (1) HRP20070429T3 (es)
IL (1) IL186355A (es)
MX (1) MX2007012445A (es)
MY (1) MY137969A (es)
NO (1) NO340520B1 (es)
NZ (1) NZ562124A (es)
PE (1) PE20061311A1 (es)
PL (2) PL1917267T3 (es)
PT (2) PT1710245E (es)
RS (1) RS50532B (es)
RU (1) RU2405786C2 (es)
SI (2) SI1710245T1 (es)
SV (1) SV2006002473A (es)
TW (1) TWI364423B (es)
UY (1) UY29459A1 (es)
WO (1) WO2006106135A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002891A1 (es) * 2006-10-06 2008-04-18 Organon Nv Trans-5-cloro-2-metil-2,3,3a,12b-tetrahidro-1h-dibenz-[2,3:6,7]oxepino[4,5-c]pirrol 50% amorfo en base al peso total del compuesto; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de un trastorno seleccionado entre e
AU2010264670A1 (en) * 2009-06-24 2012-01-19 Merck Sharp & Dohme B.V. Injectable formulations containing asenapine and method of treatment using same
WO2011159903A2 (en) 2010-06-18 2011-12-22 Dr. Reddy's Laboratories Ltd. Asenapine maleate
WO2012066565A2 (en) * 2010-11-16 2012-05-24 Cadila Healthcare Limited Asenapine maleate amorphous and crystalline form and process for preparation thereof
EP2468750A1 (en) 2010-12-13 2012-06-27 Chemo Ibérica, S.A. Polymorphic forms of asenapine maleate and processes for their preparation
WO2012123325A1 (en) 2011-03-11 2012-09-20 Medichem S.A. NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID
ITMI20110734A1 (it) * 2011-05-02 2012-11-03 Olon Spa Sali cristallini di asenapina
EP2524920A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Asenapine Hydrochloride Salt Forms
EP2524919A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids
EP2524921A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Salts of Asenapine
WO2012156676A1 (en) * 2011-05-18 2012-11-22 Laboratorios Lesvi S.L. Monoclinic crystalline form of asenapine maleate with a specific particle size distribution
US9505771B2 (en) 2011-05-18 2016-11-29 Laboratories Lesvi S.L. Stable micronised monoclin form of asenapine maleate and its synthesis
EP2572703A1 (en) 2011-09-21 2013-03-27 Hexal AG Compressed oral dosage form for asenapine maleate
WO2013041604A1 (en) 2011-09-21 2013-03-28 Sandoz Ag Crystal form of asenapine maleate
ES2632946T3 (es) * 2012-07-26 2017-09-18 Hisamitsu Pharmaceutical Co., Inc. Parche
ITMI20121810A1 (it) 2012-10-24 2014-04-25 Chemo Iberica Sa Poliformi di maleato di asenapina e processo per la loro preparazione
US9597291B2 (en) 2012-12-11 2017-03-21 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Orally disintegrating tablet containing asenapine
WO2014127786A1 (en) 2013-02-22 2014-08-28 Zentiva, K.S. Orally disintegrating pharmaceutical composition comprising asenapine
EP3350194A4 (en) 2015-09-02 2019-04-24 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
CN110087641B (zh) 2016-12-20 2024-03-12 罗曼治疗***股份公司 含有阿塞那平和聚硅氧烷或聚异丁烯的透皮治疗***
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
CN110799180A (zh) 2017-06-26 2020-02-14 罗曼治疗***股份公司 含阿塞那平和硅氧烷丙烯酸杂化聚合物的经皮治疗***
WO2019243452A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
CZ284633B6 (cs) * 1994-03-02 1999-01-13 Akzo Nobel N. V. Farmaceutický prostředek a použití trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrolu pro výrobu farmaceutického prostředku
AU2418499A (en) * 1997-12-19 1999-07-12 Akzo Nobel N.V. Org-5222 in the treatment of depression
TWI327915B (en) * 2003-06-12 2010-08-01 Organon Nv Pharmaceutical composition comprising antipsychotic agent and use of the antipsychotic agent for treating patients with overweight

Also Published As

Publication number Publication date
CA2603509C (en) 2013-12-03
NO20075142L (no) 2007-11-05
RU2405786C2 (ru) 2010-12-10
DK1710245T3 (da) 2007-12-03
HRP20070429T3 (en) 2007-11-30
DOP2006000082A (es) 2006-11-30
EP1917267A1 (en) 2008-05-07
CY1108742T1 (el) 2014-04-09
DK1917267T3 (da) 2009-04-14
CA2603509A1 (en) 2006-10-12
ATE370954T1 (de) 2007-09-15
KR101422843B1 (ko) 2014-07-24
SV2006002473A (es) 2009-11-24
UY29459A1 (es) 2006-11-30
ES2293626T3 (es) 2008-03-16
EP1710245B1 (en) 2007-08-22
DE602006000080T2 (de) 2008-05-15
GT200600135A (es) 2006-11-07
NZ562124A (en) 2010-07-30
RU2007141198A (ru) 2009-05-20
PL1917267T3 (pl) 2009-06-30
JP2008534656A (ja) 2008-08-28
AU2006231617B2 (en) 2010-06-03
SI1710245T1 (sl) 2007-12-31
RS50532B (sr) 2010-05-07
BRPI0609741A2 (pt) 2010-04-27
BRPI0609741A8 (pt) 2018-03-13
AU2006231617A1 (en) 2006-10-12
DE602006004463D1 (de) 2009-02-05
PT1917267E (pt) 2009-02-04
AR056306A1 (es) 2007-10-03
CY1106902T1 (el) 2012-09-26
PL1710245T3 (pl) 2008-01-31
TWI364423B (en) 2012-05-21
IL186355A (en) 2016-05-31
IL186355A0 (en) 2008-01-20
WO2006106135A1 (en) 2006-10-12
MY137969A (en) 2009-04-30
JP5058151B2 (ja) 2012-10-24
EP1917267B1 (en) 2008-12-24
ES2318742T3 (es) 2009-05-01
ATE418556T1 (de) 2009-01-15
PT1710245E (pt) 2007-10-03
NO340520B1 (no) 2017-05-02
DE602006000080D1 (de) 2007-10-04
TW200722428A (en) 2007-06-16
KR20080005253A (ko) 2008-01-10
EP1710245A1 (en) 2006-10-11
PE20061311A1 (es) 2007-02-09
MX2007012445A (es) 2007-11-07
SI1917267T1 (sl) 2009-04-30

Similar Documents

Publication Publication Date Title
HN2006014095A (es) Forma cristalina ortorrombica del maleato de asenapina
NO20091395L (no) Nye tiofenderivater
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
NO20082793L (no) Nye tiofenderivater
NI201100170A (es) Inhibidores de epoxicetonas proteasa de tripéptidos cristalinos
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
EA201200506A1 (ru) СПОСОБ ПОЛУЧЕНИЯ КРИСТАЛЛИЧЕСКОЙ ФОРМЫ 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-(4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ)БЕНЗОЛА
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
HN2008001191A (es) Compuestos de biciclolactama sustituida
ECSP10010295A (es) Formulacion de anticuerpo
UY31484A1 (es) Piperidinas heteroaril-sustituidas
MA32369B1 (fr) Composes de benzene sulfonamide thiazole et oxazole
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
DOP2012000150A (es) Triazolopiridinas
SV2009002858A (es) Nueva forma polimorfica y la forma amorfa de 5- cloro-n-([(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il]-metil)-2-tiofenocarboxamida
CR9723A (es) Nueva forma cristalina de un derivado de piridazino[4,5-b] indol
DOP2005000025A (es) Compuestos de heteroaril- y fenilsulfamoilo sustituidos
AR051043A1 (es) Forma cristalina de clorhidrato de (3-cian-1h-indol-7il)-[4-(4-fluorofenetil)-piperazin-1-il]-metanona
EA201401193A1 (ru) Триарильные соединения и композиции, их содержащие
CR11423A (es) NUEVOS INHIBIDORES DE sEH Y SU USO
CL2008000585A1 (es) Compuestos derivados de nicotinamida; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada por prostaglandina d2 producida por h-pgds.
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CR11078A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas